Sutro Biopharma, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STRO research report →
Companywww.sutrobio.com
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.
- CEO
- Jane Chung
- IPO
- 2018
- Employees
- 269
- HQ
- South San Francisco, CA, US
Price Chart
Valuation
- Market Cap
- $301.25M
- P/E
- -2.65
- P/S
- 3.02
- P/B
- -6.09
- EV/EBITDA
- -2.26
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 98.72%
- Op Margin
- -115.57%
- Net Margin
- -154.21%
- ROE
- 192.77%
- ROIC
- -64.34%
Growth & Income
- Revenue
- $102.48M · 65.18%
- Net Income
- $-191,086,000 · 15.99%
- EPS
- $-22.49 · 24.02%
- Op Income
- $-104,952,000
- FCF YoY
- 8.07%
Performance & Tape
- 52W High
- $43.85
- 52W Low
- $6.70
- 50D MA
- $30.06
- 200D MA
- $16.00
- Beta
- 1.64
- Avg Volume
- 226.69K
Get TickerSpark's AI analysis on STRO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 4, 26 | Pauling David | other | 675 |
| Mar 4, 26 | Pauling David | other | 277 |
| Mar 4, 26 | Pauling David | other | 675 |
| Mar 4, 26 | Chung Jane | other | 788 |
| Mar 4, 26 | Chung Jane | other | 282 |
| Mar 4, 26 | Chung Jane | other | 788 |
| Mar 2, 26 | Pauling David | other | 33,600 |
| Mar 2, 26 | Pauling David | other | 2,356 |
| Mar 2, 26 | Pauling David | other | 970 |
| Mar 1, 26 | Pauling David | other | 842 |
Our STRO Coverage
We haven't published any research on STRO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate STRO Report →